Beyond Air Inc (XAIR) Stock Analysis

Beyond Air Inc (XAIR) is a publicly traded company in the HEALTHCARE sector. It trades at $0.47, carries a market capitalization of $6.17M. This page summarizes the public market data, fundamentals, and frequently asked questions for XAIR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Beyond Air Inc currently has a Neutral sentiment score of 0.13.

About Beyond Air Inc

Beyond Air, Inc. (Ticker: XAIR) is a clinical-stage biopharmaceutical and medical device company specializing in innovative nitric oxide (NO) generators and delivery systems aimed at addressing critical unmet medical needs. With a strong focus on developing therapies for respiratory disorders and other centralized applications, Beyond Air seeks to enhance patient outcomes through its proprietary technology. Headquartered in Garden City, New York, the company is positioned to leverage its scie...

GNG Research Analysis

GNG Research scores Beyond Air Inc (XAIR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XAIR.

Frequently Asked Questions

Does XAIR pay dividends?

Beyond Air Inc (XAIR) does not currently pay a regular dividend.

What is XAIR's market cap?

Beyond Air Inc (XAIR) has a market capitalization of $6.17M with a current stock price of $0.47.